Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies.
Yazdani A, Yazdani A, Mendez-Giraldez R, Pillonetto G, Samiei E, Hadi R, Lenz HJ, Venook A, Samiei A, Nixon A, Lucci J, Kopetz S, Bertagnolli M, Perou C, Innocenti F. Yazdani A, et al. Among authors: bertagnolli m. Res Sq [Preprint]. 2024 Mar 11:rs.3.rs-4047331. doi: 10.21203/rs.3.rs-4047331/v1. Res Sq. 2024. PMID: 38559223 Free PMC article. Preprint.
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.
Abou-Alfa GK, Geyer SM, Nixon AB, Innocenti F, Shi Q, Kumthekar P, Jacobson S, El Dika I, Yaqubie A, Lopez J, Huang B, Tang YW, Wen Y, Schwartz LH, El-Khoueiry AB, Knox JJ, Rajdev L, Bertagnolli MM, Meyerhardt JA, O'Reilly EM, Venook AP. Abou-Alfa GK, et al. Among authors: bertagnolli mm. Cancer Res Commun. 2024 Mar 7;4(3):682-690. doi: 10.1158/2767-9764.CRC-22-0516. Cancer Res Commun. 2024. PMID: 38363156 Free PMC article. Clinical Trial.
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy.
Yazdani A, Lenz HJ, Pillonetto G, Mendez-Giraldez R, Yazdani A, Sanof H, Hadi R, Samiei E, Venook AP, Ratain MJ, Rashid N, Vincent BG, Qu X, Wen Y, Kosorok M, Symmans WF, Shen JPYC, Lee MS, Kopetz S, Nixon AB, Bertagnolli MM, Perou CM, Innocenti F. Yazdani A, et al. Among authors: bertagnolli mm. Res Sq [Preprint]. 2023 Dec 15:rs.3.rs-3673588. doi: 10.21203/rs.3.rs-3673588/v1. Res Sq. 2023. PMID: 38168324 Free PMC article. Preprint.
The Influence of Social Determinants on Receiving Outpatient Treatment with Monoclonal Antibodies, Disease Risk, and Effectiveness for COVID-19.
Ambrose N, Amin A, Anderson B, Bertagnolli M, Campion F, Chow D, Danan R, D'Arinzo L, Drews A, Erlandson K, Fitzgerald K, Gaspar F, Gong C, Hanna G, Hawley H, Jones S, Lopansri B, Mullen T, Musser J, O'Horo J, Piantadosi S, Pritt B, Razonable R, Rele S, Roberts S, Sandmeyer S, Stein D, Te J, Vahidy F, Webb B, Welch N, Wood A, Yttri J. Ambrose N, et al. Among authors: bertagnolli m. J Gen Intern Med. 2023 Dec;38(16):3472-3481. doi: 10.1007/s11606-023-08324-y. Epub 2023 Sep 15. J Gen Intern Med. 2023. PMID: 37715096
Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes.
Ambrose N, Amin A, Anderson B, Barrera-Oro J, Bertagnolli M, Campion F, Chow D, Danan R, D'Arinzo L, Drews A, Erlandson K, Fitzgerald K, Garcia M, Gaspar FW, Gong C, Hanna G, Jones S, Lopansri B, Musser J, O'Horo J, Piantadosi S, Pritt B, Razonable RR, Roberts S, Sandmeyer S, Stein D, Vahidy F, Webb B, Yttri J. Ambrose N, et al. Among authors: bertagnolli m. JAMA Netw Open. 2023 Apr 3;6(4):e239694. doi: 10.1001/jamanetworkopen.2023.9694. JAMA Netw Open. 2023. PMID: 37093599 Free PMC article.
236 results